CLARITY BEFORE DECISIONS
Understand your options.
“Bioidentical” describes hormones chemically matching those made by the body. It is not a separate FDA approval category. Some FDA-approved estradiol and progesterone products meet that description.
At Thrive, treatment conversations begin with your goals and a medical evaluation. Choosing to explore a service does not commit you to treatment.
YOUR HEALTH COMES FIRST
Who may consider an evaluation?
Patients comparing hormone claims can discuss symptoms, medical history, approved options, and whether a specific preparation is appropriate.
Share sensitive health details through the clinic’s appropriate clinical intake process, rather than a general website questionnaire.
Potential benefits.
Realistic expectations.
Benefits come from the particular hormone, dose, route, and indication, not the marketing term. Approved options have product-specific evidence.
Important limitations
Exact available products, formulations, and routes must be confirmed with Thrive. FDA-approved products and compounded preparations are different. Compounded hormones are not FDA-approved, and “bioidentical” does not establish greater safety or effectiveness.
INFORMED CARE
Make room for the safety conversation.
Hormones retain their medical risks regardless of the bioidentical label. Compounded preparations add uncertainty about quality, potency, and evidence.
This is an educational overview, not complete safety information. Your clinician should review current product labeling, your medical history, and alternatives before treatment. Do not start, stop, or adjust a prescription based on this page.
What to expect.
Ask which product is proposed, whether it is FDA-approved, why it is being considered, and how benefit and adverse effects will be monitored.
- Start with your priorities. Discuss your goals and the concerns you want to understand.
- Review the details. Ask about evidence, alternatives, expected recovery, risks, and total cost.
- Agree on the next step. If treatment is appropriate, your provider explains the plan and follow-up.
Cherry, CareCredit, and eligible Affirm options are subject to approval and applicable terms. HSA/FSA use depends on the service and your plan. Financing does not establish medical eligibility.
A MORE INFORMED START
Your questions, answered.
Is hormone therapy appropriate for everyone?
No. Symptoms, diagnosis, medical history, preferences, and the risks of a particular product determine the next step.
Are compounded hormones safer?
FDA has not established that compounded hormone therapy is safer or more effective than FDA-approved options.
Will I need follow-up?
If therapy is prescribed, monitoring is individualized to the product, condition, and clinical response.
Can I request a telehealth consultation?
Appropriate telehealth consultations may be available. The clinic confirms whether your needs, location, and applicable examination or prescribing requirements allow a remote visit.
Can I use financing or HSA/FSA funds?
Explore Thrive’s payment options. Financing approval and eligible expenses depend on the provider, service, and your individual plan.
Continue exploring.
For additional background on the evidence and safety considerations discussed above, read FDA: menopause and hormone therapy. Your provider reviews the latest applicable information before care.
Treatment options are determined by a licensed medical provider following an individualized evaluation. Results vary, and not all treatments are appropriate for every patient.